Rosiglitazone is effective in obese and non-obese patients with Type 2 diabetes

被引:0
|
作者
Deacon, L
Donnelly, S
Stewart, M
Hand, L
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A433 / A433
页数:1
相关论文
共 50 条
  • [11] Thioazolidinediones are useful in treating non-obese patients with type 2 diabetes mellitus
    Tanaka, Y
    Kitamura, R
    Seo, M
    Ihara, Y
    Yamamoto, Y
    Ogata, T
    Motoyoshi, K
    DIABETES, 2002, 51 : A134 - A135
  • [12] METABOLIC SURGERY FOR NON-OBESE TYPE 2 DIABETES MELLITUS ASIAN PATIENTS
    Lee, Wei-Jei
    Ser, Kong-Han
    Lee, Ming-Hsien
    Chen, Shu-Chu
    Tsou, Jun-Juin
    Chen, Jung-Chien
    OBESITY SURGERY, 2015, 25 (08) : 1310 - 1310
  • [13] Type 2 diabetes in the non-obese children and adolescents in Bangladesh
    Sayeed, M. A.
    Mahtab, H.
    Banu, A.
    Khanam, P. A.
    Latif, Z. A.
    Ahmed, A. U.
    Nahar, J. S.
    Khatun, K.
    Khan, A. Azad
    DIABETOLOGIA, 2008, 51 : S175 - S175
  • [14] Addition of rosiglitazone to metformin is effective in obese, insulin-resistant patients with type 2 diabetes
    Jones, T
    Jones, NP
    Sautter, M
    DIABETOLOGIA, 2000, 43 : A191 - A191
  • [15] Serum levels of fibronectin and endothelin-1 in obese and non-obese patients with Type 2 diabetes mellitus
    Mogylnytska, L
    Mankovsky, B
    DIABETOLOGIA, 2004, 47 : A455 - A456
  • [16] Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients
    Dominique Hansen
    Paul Dendale
    Milou Beelen
    Richard A. M. Jonkers
    Annelies Mullens
    Luk Corluy
    Romain Meeusen
    Luc J. C. van Loon
    European Journal of Applied Physiology, 2010, 109 : 397 - 404
  • [17] Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients
    Hansen, Dominique
    Dendale, Paul
    Beelen, Milou
    Jonkers, Richard A. M.
    Mullens, Annelies
    Corluy, Luk
    Meeusen, Romain
    van Loon, Luc J. C.
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2010, 109 (03) : 397 - 404
  • [18] Evaluation of Effective Dose During Ureteroscopy for Obese and Non-Obese Patients
    Wang, C.
    Nguyen, G.
    Chung, Y.
    Cabrera, F.
    Shins, R.
    Lipkin, M.
    Yoshizumi, T.
    MEDICAL PHYSICS, 2014, 41 (06) : 103 - 103
  • [19] Different β-cell secretory phenotype in non-obese compared to obese early type 2 diabetes
    Gudipaty, Lalitha
    Rosenfeld, Nora K.
    Fuller, Carissa S.
    Cuchel, Marina
    Rickels, Michael R.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (05)
  • [20] Markers for obese and non-obese Type 2 diabetes identified using whole blood metabolomics
    Takayuki Teruya
    Sumito Sunagawa
    Ayaka Mori
    Hiroaki Masuzaki
    Mitsuhiro Yanagida
    Scientific Reports, 13